Tandem Diabetes Care Inc
NASDAQ:TNDM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
US |
|
U
|
Ulta Beauty Inc
LSE:0LIB
|
US |
|
Vertex Resource Group Ltd
XTSX:VTX
|
CA |
|
G
|
General Mills Inc
XBER:GRM
|
US |
|
A
|
Andlauer Healthcare Group Inc
TSX:AND
|
CA |
|
Ur-Energy Inc
TSX:URE
|
US |
|
MSA Safety Inc
NYSE:MSA
|
US |
|
Rathbones Group PLC
LSE:RAT
|
UK |
|
Owens & Minor Inc
NYSE:OMI
|
US |
|
G
|
Gunkul Engineering PCL
SET:GUNKUL
|
TH |
|
Stem Inc
NYSE:STEM
|
US |
|
Amplitude Energy Ltd
ASX:AEL
|
AU |
|
Preformed Line Products Co
NASDAQ:PLPC
|
US |
|
Incyte Corp
NASDAQ:INCY
|
US |
|
Healthcare Services Group Inc
NASDAQ:HCSG
|
US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
US |
|
Hudson Global Inc
NASDAQ:HSON
|
US |
|
Main Street Capital Corp
NYSE:MAIN
|
US |
|
mBank SA
OTC:MBAKF
|
PL |
|
Ionic Rare Earths Ltd
ASX:IXR
|
AU |
|
MGM Resorts International
NYSE:MGM
|
US |
Wall St Price Targets
TNDM Price Targets Summary
Tandem Diabetes Care Inc
According to Wall Street analysts, the average 1-year price target for
TNDM is 29.78 USD with a low forecast of 17.17 USD and a high forecast of 52.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TNDM's stock price target?
Price Target
29.78
USD
According to Wall Street analysts, the average 1-year price target for
TNDM is 29.78 USD with a low forecast of 17.17 USD and a high forecast of 52.5 USD.
What is the Revenue forecast for Tandem Diabetes Care Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 8 years is 8%.